{
  "paper_metadata": {
    "pmid": "28222693",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5986G>A",
      "protein_notation": "p.Ala1996Thr",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Indian women",
        "phenotype": "healthy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "healthy",
          "evidence_sentence": "BRCA2 p.Ala1996Thr which is predicted to be likely pathogenic by in-silico models is presented in 2% of healthy Indian women suggesting that it may not be associated with breast cancer risk."
        }
      ],
      "functional_data": {
        "summary": "Predicted to be likely pathogenic by in-silico models.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": "2% in healthy Indian women",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as likely pathogenic but found in healthy individuals.",
      "key_quotes": [
        "BRCA2 p.Ala1996Thr which is predicted to be likely pathogenic by in-silico models is presented in 2% of healthy Indian women suggesting that it may not be associated with breast cancer risk."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.10234A>G",
      "protein_notation": "p.Ile3412Val",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": 1,
        "demographics": "unaffected women",
        "phenotype": "healthy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "healthy",
          "evidence_sentence": "Our study confirmed BRCA2 p.Ile3412Val is presented in >2% of unaffected women and is likely benign."
        }
      ],
      "functional_data": {
        "summary": "Classified as likely benign.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": ">2% in unaffected women",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as likely benign based on population frequency.",
      "key_quotes": [
        "Our study confirmed BRCA2 p.Ile3412Val is presented in >2% of unaffected women and is likely benign."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.943T>C",
      "protein_notation": "p.Cys315Ser",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": 1,
        "demographics": "unaffected women",
        "phenotype": "healthy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "healthy",
          "evidence_sentence": "BRCA2 p.Cys315Ser is likely benign."
        }
      ],
      "functional_data": {
        "summary": "Classified as likely benign.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": "1.2% in healthy controls",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as likely benign based on population frequency.",
      "key_quotes": [
        "BRCA2 p.Cys315Ser is likely benign."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6322C>T",
      "protein_notation": "p.Arg2108Cys",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": 1,
        "demographics": "unaffected women",
        "phenotype": "healthy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "healthy",
          "evidence_sentence": "BRCA2 p.Arg2108Cys is likely benign."
        }
      ],
      "functional_data": {
        "summary": "Classified as likely benign.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": "1.1% in healthy controls",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as likely benign based on population frequency.",
      "key_quotes": [
        "BRCA2 p.Arg2108Cys is likely benign."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8187G>A",
      "protein_notation": "p.Lys2729Asn",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": 1,
        "demographics": "unaffected women",
        "phenotype": "healthy"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "healthy",
          "evidence_sentence": "BRCA2 p.Lys2729Asn is likely benign."
        }
      ],
      "functional_data": {
        "summary": "Classified as likely benign.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": "1.3% in healthy controls",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as likely benign based on population frequency.",
      "key_quotes": [
        "BRCA2 p.Lys2729Asn is likely benign."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "BRCA2 variants detected in Malaysian carriers by genotyping",
      "variants_extracted": 5
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 5,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted with detailed penetrance data."
  }
}